I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02923427 |
|
Recruitment Status :
Completed
First Posted : October 4, 2016
Results First Posted : October 8, 2020
Last Update Posted : October 27, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Airway Morbidity Anaesthesia | Device: Laryngeal mask Supreme Evaluation Device: i-gel Evaluation | Not Applicable |
Prospective, randomized and double-blind study, aged from 18 to 65 years undergoing elective laparoscopic gynecological surgery.
The patients are randomly assigned to 2 groups:
- Group 1: i-gel
- Group 2: LMA- Supreme
Procedure:
The investigation protocol contains the following sections:
- Induction of anaesthesia. For preoperative sedation 0.02 mg/kg midazolam IV will be administered. 2 minutes of 0.2 µ/kg/min remifentanil and 6 mg kg st-1 propofol infusion, IV 1-2 mg kg-1 propofol . No muscle relaxant will be used for insertion of the airway device.
- Bispectral index values will be held between 40-60.Bispectral index values will be within this interval by increasing or decreasing propofol infusion by 1 mg/kg after additional bolus dose of propofol (1 mg/kg).
- Insertion of the airway device. The size of the airway device used is based on the manufacturers' recommendations. All devices are deflated a lubricated prior to use. Once inserted, the cuff is be inflated with a manometer up to 60 cm H20 Data recorded: size of airway device, time an number of attempts.
- Anesthesia maintenance will be ensured by 50% O2/air with 0.1-0.4 µ kg/min-1 remifentanil and 50-150 µ kg/ min-1 (4-10 mg/kg/hr) propofol IV infusion
- Functionality of the gastric drainage channel of the airway device: passage of a 14 G size tube.
- Measurement of airway seal pressure (oropharyngeal leak pressure (OLP): at baseline, and at 2 minutes after airway device insertion (T1), 10 minutes after insufflation (T2), before desufflation (T3), before removal of airway device (T4). The maximum pressure allowed is 40 cm H2O.
- Ventilatory mechanics and parameters and hemodynamic parameters are measured at baseline, and at T1, T2, T3 and T4.
- Perioperative complications: Cough, vomiting, laryngeal spasm, laryngeal Stridor, airway intervention requirements, hypoxia (SpO2 < 92%)
- Removal of the airway device: Presence of blood - 3 level grading (1:no blood; 2: trace amounts of blood; 3: clear amounts of blood). Complications: sore throat ( VAS:10-point scale), dysphonia (yes/no), dysphagia (yes/no).
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 112 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Comparison of I-gel and LMA Supreme Without Neuromuscular Blocker in Laparoscopic Gynecological Surgery |
| Actual Study Start Date : | November 2015 |
| Actual Primary Completion Date : | September 2017 |
| Actual Study Completion Date : | November 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Laryngeal mask Supreme
Insertion of the "Laryngeal mask Supreme" and evaluation of its clinical performance
|
Device: Laryngeal mask Supreme Evaluation
Evaluation of clinical performance in terms of Insertion, ventilation and complications |
|
Experimental: i-gel
Insertion of the "i-gel" and evaluation of its clinical performance
|
Device: i-gel Evaluation
Evaluation of clinical performance in terms of Insertion,ventilation and complications |
- Airway Seal Pressure Values [ Time Frame: At baseline and at 15, 30 and 60 minutes ]This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.
- Visual Quality [ Time Frame: during pneumoperitoneum ]quality of surgical view will evaluate by the scala. quality of surgical view will be assessed with points from 1 to 4 by the surgeon blind to the airway device; (1:best, 4: worst).
- Gastric Tube Insertion [ Time Frame: following airway device insertion up to 5 minutes ]Number of Participants According to Ease of Gastric Tube Insertion.Ease of passage of a gastric tube as: very easy, easy, difficult or very difficult.
- Postoperative Pharyngolaryngeal Morbidity [ Time Frame: postoperative first hour and 24th hour ]Sore throat evaluted by Visual Analogue Scale. The visual analog scale, also known as the graphic rating scale is a simple, valid and reliable subjective measure. Scores are ranked on a 10-cm line that stretches between two extremes - "no pain" and "worst pain". Total range provided"0 (no pain) to 10 (worst pain).
- Sufficiency of Pneumoperitoneum [ Time Frame: baseline ]Number of Participants with Sufficiency of Pneumoperitoneum. Sufficiency of pneumoperitoneum for the surgical procedure according to surgeon, described as sufficient or insufficient questionaire.
- Mean Airway Pressure Values [ Time Frame: At baseline and at 15, 30 and 60 minutes ]Mean airway pressure typically refers to the mean pressure applied during positive-pressure mechanical ventilation. Mean airway pressure correlates with alveolar ventilation, arterial oxygenation, hemodynamic performance, and barotrauma.
- Dysphonia With Yes/no. [ Time Frame: postoperative first hour and 24th hour ]We evaluated while a patient was talking with us that the patient has dysphonia or not .
- Disphagia [ Time Frame: postoperative first hour and 24th hour ]We asked the question that you have a pain while you were swallowing, yes or not.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- American Society of Anesthesiologists classification group I-II
- between 18-65 years
- undergoing elective laparoscopic gynecological surgery
Exclusion Criteria:
- Those with any neck or upper respiratory tract pathology
- Those at risk of gastric content regurgitation/aspiration (previous upper Gastrointestinal system surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcers, full stomach, pregnancy)
- Those with low pulmonary compliance or high airway resistance (chronic pulmonary diseases)
- Obese patients (BMI >35)
- Those with throat pain, dysphagia and dysphonia
- Those with possible or previous difficult airway
- Those with operations planned for longer than 4 hours
- Conversion to laparatomy
- Neuromuscular blocking agent used
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02923427
| Turkey | |
| Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation | |
| İzmir, Turkey, 35340 | |
| Study Director: | Ferim Günenç, MD | Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation |
Documents provided by Sule Ozbilgin, Dokuz Eylul University:
| Responsible Party: | Sule Ozbilgin, Dokuz Eylul University, MD, Anesthesiologists., Dokuz Eylul University |
| ClinicalTrials.gov Identifier: | NCT02923427 |
| Other Study ID Numbers: |
266-SBKAEK |
| First Posted: | October 4, 2016 Key Record Dates |
| Results First Posted: | October 8, 2020 |
| Last Update Posted: | October 27, 2020 |
| Last Verified: | October 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
|
laryngeal mask Supreme i-gel laparoscopic gynecological surgery |

